0.38
0.38 (0%)
As of Apr 25, 2025
Aethlon Medical Inc [AEMD]
Source:
Company Overview
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections and for use in organ transplantation.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | (619) 941-0360 |
| Industry | manufacturing |
| CEO | James B. Frakes |
| Website | www.aethlonmedical.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-2.6 |
| Net Income | |
| Net Cash | $3.6 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | |
| Profit as % of Stockholder Equity |
Management Effectiveness
| Return on Equity | -29.5% |
| Return on Assets | -22.5% |
| Turnover Ratio | |
| EBITA | $-2.6 |
Balance Sheet and Cash Flow Measures
| Total Assets | $11.4 |
| Total Liabilities | $2.7 |
| Operating Cash Flow | $-1.7 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $5.4 |
